Ravi Sirdeshmukh (Hindi: रवि सरदेशमुख) is an Indian cancer biologist and proteomicist.[1] He is a distinguished scientist and incumbent associate director of the Institute of Bioinformatics (IOB) in Bangalore, founding president of the Proteomics Society of India and senior research advisor at the Mazumdar Shaw Center for Translational Research (MSCTR) in Bangalore.[2][3][4] He is also an elected member of the Council of Human Proteome Organization.[5][6] He is most noted for his contributions in the Human Proteome Project where he served as the Group Leader for the countries like India, Singapore, Taiwan and Thailand. Sirdeshmukh is also an invited member of the Council of Asian Oceanean HUPO (AOHUPO).[7]

Education and career

Sirdeshmukh graduated with an M.Sc. in Biochemistry from Osmania University in Hyderabad, India. He then completed his Ph.D. at the Centre for Cellular and Molecular Biology (CCMB) in Hyderabad. He worked in the USA as a visiting researcher at the Washington University Medical School and the National Institutes of Health.[8]

Sirdeshmukh worked at CCMB for more than two decades and headed the proteomics laboratory as director before joining the Institute of Bioinformatics (IOB) as a distinguished scientist. He also works as a consultant in neuro-oncology research at the Mazumdar-Shaw Center for Translational Research (MSCTR), where he leads transnational research programs on brain tumors. Ravi Sirdeshmukh is a member of the research advisory boards of several institutes and centers, such as the US Pharmacopeia (USP) for protein therapeutics, the Human Proteome Organization (HUPO) and the Asian Oceanian HUPO (AOHUPO). He was also thereby connected to international research initiatives such as the Membrane Proteomics Initiative of AOHUPO and the Chromosome-Centric Human Proteome Project initiated by HUPO.[9]

Sirdeshmukh is also a reviewer for various international proteomics journals and a member of the editorial board of the International Journal of Proteins and Proteomics. He is also the founding president of the Proteomics Society India.[7]

Research area

His research interests extend to the areas of protein and nucleic acid biochemistry and his previous work includes RNA processing, mRNA stability, structure-function relationship of ribonucleases and their regulation. More recently, his interest has been in the areas of proteomics of gliomas – a major class of brain tumors and head and neck cancers.

Honors and positions

Sirdeshmukh has been honored with memberships in several national and international bodies. This includes[7]

Selected publications

References

  1. "Ravi Sirdeshmukh's Biography". Indian Lab Automation. Retrieved 2023-11-23.
  2. "Ravi Sirdeshmukh, Ph.D." Institute of Bioinformatics. Retrieved 2023-11-22.
  3. "PSI Members". Proteomics Society, India. Retrieved 2023-11-23.
  4. "Committee Members". 8th Annual Meeting of Proteomics Society, India. Retrieved 2023-11-23.
  5. "PI: Ravi Sirdeshmukh, Ph.D." Human Proteome Organization. Retrieved November 23, 2023.
  6. Sirdeshmukh, Ravi; m. Zingde, Surekha; Dharmalingam, K.; a. Vijayalakshmi, Mookambeswaran (27 August 2015). "Bench to bedside: Still a pipedream? Nature India Special Issue: Proteomics Research in India". Nature India. doi:10.1038/nindia.2015.113. Retrieved August 27, 2015.
  7. 1 2 3 "Ravi Sirdeshmukh, Ph.D." India Cancer Research Database. Retrieved November 23, 2023.
  8. "Dr. Ravi Sirdeshmukh". Mazumbdar Shaw Center for Translational Research. June 6, 2016. Retrieved November 23, 2023.
  9. Chaiyarit, Sakdithep; Singhto, Nilubon; Chen, Yi-Ju; Cheng, Chia-Ying; Chiangjong, Wararat; Kanlaya, Rattiyaporn; Lam, Henry H. N.; Peerapen, Paleerath; Sung, Ting-Yi; Tipthara, Phornpimon; Pandey, Akhilesh; Poon, Terence C. W.; Chen, Yu-Ju; Sirdeshmukh, Ravi; Chung, Maxey C. M.; Thongboonkerd, Visith (2014). "Chromosome-centric Human Proteome Project (C-HPP): Chromosome 12". Figshare. 13 (7): 3160–3165. doi:10.1021/pr500009j. PMID 24831074. Retrieved 2014-07-03.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.